{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T05:02:10Z","timestamp":1733115730762,"version":"3.30.0"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":8431,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[1992,8]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>To test whether interferon can prevent acute non\u2013A, non\u2013B hepatitis from becoming chronic, a prospective controlled trial was conducted in 25 patients; 11 were treated for an average of 30 days with a mean of 52 megaunits of interferon and 14 acted as controls. 4 patients in the treatment group who continued to have raised serum aminotransferase concentrations after a year's follow\u2013up were given a second course of interferon. Follow\u2013up at 3 years has revealed that all but 1 of those treated showed normal serum aminotransferase, whereas only 3 controls showed such change (p &lt; 0.02). Serum hepatitis C virus RNA became undetectable in 10 of 11 treated and in only 1 of 12 control patients, which suggests that interferon prevents the progression of acute non\u2013A, non\u2013B hepatitis to chronicity by eradicating HCV.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.1840160232","type":"journal-article","created":{"date-parts":[[2007,3,4]],"date-time":"2007-03-04T01:12:14Z","timestamp":1172970734000},"page":"497-498","update-policy":"http:\/\/dx.doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Therapy of Acute Hepatitis C With Interferon: How Good Is It Really?"],"prefix":"10.1097","volume":"16","author":[{"given":"Jorge J.","family":"Gumucio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Rakela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David D.","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1002\/hep.1840160232-BIB1","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1056\/NEJM198911303212203","volume":"321","author":"Davis","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1002\/hep.1840160232-BIB2","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM198911303212204","volume":"321","author":"Di Bisceglie","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1002\/hep.1840160232-BIB3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0016-5085(83)90336-0","volume":"85","author":"Dienstag","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1002\/hep.1840160232-BIB4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/hep.1840140227","volume":"14","author":"Houghton","year":"1991","journal-title":"HEPATOLOGY"},{"key":"10.1002\/hep.1840160232-BIB5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7326\/0003-4819-116-1-51","volume":"116","author":"Papo","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1002\/hep.1840160232-BIB6","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0140-6736(89)91595-X","volume":"2","author":"Vento","year":"1989","journal-title":"Lancet"},{"key":"10.1002\/hep.1840160232-BIB7","first-page":"612","volume-title":"Viral hepatitis and liver disease","author":"Thomas","year":"1991","unstructured":"Pathogenesis of chronic HBV infection and mechanisms of action of antiviral compounds. In: , . Viral hepatitis and liver disease. Baltimore: Williams and Wilkins, 1991: 612\u2013615."}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.1840160232","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-199208000-00031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T11:03:33Z","timestamp":1733051013000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-199208000-00031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,8]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1992]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.1840160232","relation":{},"ISSN":["0270-9139"],"issn-type":[{"type":"print","value":"0270-9139"}],"subject":[],"published":{"date-parts":[[1992,8]]}}}